Clinical Trials Sponsored by Caretech Innovation

Total 2069 results

Regionshospitalet Silkeborg
Lundbeck Foundation; Caretech Innovation

Completed

A Telemedicine Solution for Remote Support of Rehabilitation, for Patients Undergoing, Total Hip Arthroplasty Surgery (RRS)

Quality of Life | Anxiety

Denmark
CureTech Ltd

Completed

CT-011 MAb in DLBCL Patients Following ASCT

Primary Mediastinal Large B-Cell Lymphoma | Lymphoma, Large Cell, Diffuse | Lymphoma, Mixed Cell, Diffuse

United States, Israel, India
Africa Power Limited
Malaria Consortium; ARCTECH INNOVATION LIMITED

Not yet recruiting

Evaluation of the Protective Efficacy of a Spatial Repellent to Reduce Malaria Prevalence in Uganda (Mossie-GO)

Malaria | Mosquito-Borne Disease
PureTech

Recruiting

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Solid Tumor | Metastatic Cancer | Urothelial Carcinoma

United States
PureTech

Recruiting

A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)

MDS | AML, Adult Recurrent

United States
PureTech

Recruiting

LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (ELEVATE)

Idiopathic Pulmonary Fibrosis

United States, Korea, Republic of, Georgia, Malaysia, Greece, Mexico, Thailand, India, Philippines, Argentina, Romania, South Africa, Chile, Colombia
AceTech

Active, not recruiting

Characterization of Skin Microbiome Profile and it's Correlation to Radiation Dermatitis

Radiation Dermatitis

Israel
AceTech

Recruiting

The Effect of RadiaAce Gel in the Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients

Breast Cancer | Radiation Dermatitis

Israel
Acrotech Biopharma Inc.

Recruiting

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL (CRESCENDO)

Peripheral T Cell Lymphoma

United States
Acrotech Biopharma Inc.

Withdrawn

Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®

Non-Small Cell Lung Cancer
Acrotech Biopharma Inc.

Completed

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

B-cell Lymphoma | Hodgkin's Lymphoma | Relapsed or Refractory Lymphoproliferative Malignancies | Peripheral T-cell Lymphoma | Waldenstrom's Macroglobulinemia

United States
Acrotech Biopharma Inc.

Completed

Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer

Breast Cancer | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Human Mammary Carcinoma

France, United States, Czechia, Hungary
Acrotech Biopharma Inc.

Active, not recruiting

A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
Acrotech Biopharma Inc.

Withdrawn

Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn

Non Hodgkin's Lymphoma
Acrotech Biopharma Inc.

Completed

Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Cutaneous T-cell Lymphoma

United States
Acrotech Biopharma Inc.

Completed

Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHL

Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large B-cell Lymphoma

United Kingdom, United States
Acrotech Biopharma Inc.

Completed

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Mycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma | Primary Cutaneous Anaplastic Large Cell Lymphoma

United States, Italy
Acrotech Biopharma Inc.

Completed

Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder

Carcinoma, Transitional Cell | Bladder Cancer | Bladder Neoplasm

Spain, France, Belgium, United States, Argentina, Croatia
Acrotech Biopharma Inc.

Completed

Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

United States
Acrotech Biopharma Inc.

Completed

This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)

Atopic Dermatitis

United States
ParaTech A/S

Completed

Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO) (PROCTO)

Ulcerative Colitis Chronic Moderate

Denmark
Acrotech Biopharma Inc.

Completed

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry (COMPLETE)

Peripheral T-cell Lymphoma

United States
Acrotech Biopharma Inc.

Completed

Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)

Peripheral T-cell Lymphoma

United States
Acrotech Biopharma Inc.

Completed

Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced Cancer

Advanced Cancer

Spain
Acrotech Biopharma Inc.

Completed

Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PROPEL)

Peripheral T-cell Lymphoma

United States, United Kingdom, Canada, France, Italy, Belgium
Acrotech Biopharma Inc.

Completed

PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation

Multiple Myeloma

United States
Acrotech Biopharma Inc.

Completed

Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction

Malignant Melanoma

United States
M.D. Anderson Cancer Center
CureTech Ltd

Completed

Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma

Lymphoma

United States
Exactis Innovation

Recruiting

An Observational Study to Evaluate the Clinical Utility of the Oncomine Precision Assay Within the Exactis Network

NSCLC

Canada
Exactis Innovation

Recruiting

Personalize My Treatment (PMT) Registry (PMT)

Cancer

Canada
Acrotech Biopharma Inc.
Onxeo

Completed

MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC

Stage IV Non-small Cell Lung Cancer

United States
Alfact Innovation

Unknown

Efficacy & Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis & Early Stage Acute Liver Failure

Liver Failure, Acute

France
NeoPlas Innovation

Withdrawn

Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma

Melanoma | Malignant Melanoma

United States
Planet Innovation

Recruiting

Evaluating the Usability of the Product Kinder System Trial, Home Based Hormone for In-Vitro Fertilization (IVF) Monitoring System.

Fertility Disorders

Singapore
Millet Innovation

Completed

Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return

Quality of Life | Symptoms and Signs | Venous Disease

Portugal
Open Innovation Partners, Inc.
Open Innovation Partners

Suspended

TR1801-ADC in Patients With Tumors That Express c-Met

Unspecified Adult Solid Tumor, Protocol Specific

United States
PRInnovation GmbH
Julius Clinical; Federal Agency for Disruptive Innovation - SPRIN-D; Priavoid

Recruiting

Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD) (PRImus-AD)

Mild Cognitive Impairment Due to Alzheimer's Disease | Alzheimer's Disease, Early Onset

Spain, Italy, Germany, Netherlands, Czechia, France, Poland
Maimónides Biomedical Research Institute of Córdoba
TECNALIA Research & Innovation; GMV Innovating Solutions

Completed

Usability Study of "ArmAssist 2.0." Robot: Homecare Arm Rehabilitation in Stroke Patients (PUAA)

Stroke | Rehabilitation | Telerehabilitation | Upper Limb Rehabilitation | Robot-assisted Therapy

Spain
PureTech
Novotech (Australia) Pty Limited

Recruiting

LYT-300 in Healthy Volunteers

Healthy Volunteers

Australia
PureTech
Novotech (Australia) Pty Limited

Terminated

LYT-100 in Patients With BCRL

Lymphoedema | Breast Cancer Related Lymphoedema

United States, Australia
Innovation Research & Training

Recruiting

Mindfulness Program for Adolescents With 22q11DS

22Q11 Deletion Syndrome

United States
Hip Innovation Technology

Recruiting

Safety and Effectiveness of the HIT Reverse HRS

Osteoarthritis, Hip | Avascular Necrosis of Hip | Degenerative Joint Disease | Traumatic Arthropathy-Hip

United States
Innovation Hub Enterprises

Not yet recruiting

COPD Remote Patient Monitoring Through Connected Devices

Chronic Obstructive Pulmonary Disease

United States
Hip Innovation Technology

Recruiting

Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty ((HRS-P))

Osteoarthritis of Hip

Canada
Orthopaedic Innovation Centre

Active, not recruiting

Staged Versus Simultaneous Bilateral Knee Arthroplasty

Knee Osteoarthritis

Canada
Orthopaedic Innovation Centre

Active, not recruiting

REDAPT Revision Hip System With RSA

Hip Osteoarthritis

Canada
Orthopaedic Innovation Centre

Completed

COVID-19 Nasal Swab Trial

Covid19

Canada
Innovation Research & Training

Completed

Web-based Resource for Children and Adolescents About Clinical Research

Healthy | Chronic Illnesses, Multiple

United States
Innovation Research & Training

Completed

Birds and Bees Research Study

Communication | Sexual Behavior

United States
Arthritis Innovation Corporation

Completed

Safety and Activity of F14 for Management of Pain Following Total Knee Replacement

Postoperative Pain | Total Knee Replacement

United States

Clinical Trials Sponsored by Caretech Innovation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations